share_log

Cellectar BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(9.676%),Lincoln Park Capital, LLC(9.676%), etc.

Cellectar BioSciences | SC 13G/A:超過5%持股股東披露文件(修正)-Lincoln Park Capital Fund, LLC(9.676%),Lincoln Park Capital, LLC(9.676%)等

美股sec公告 ·  02/14 16:35
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息